Khaled Greish Selected Research

Styrene (Styrol)

1/2019	A multivariate statistical analysis of the effects of styrene maleic acid encapsulated RL71 in a xenograft model of triple negative breast cancer.
12/2017	Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease.
1/2017	Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer.
2/2016	pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
1/2016	Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model.
9/2015	The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer.
7/2015	Styrene maleic acid copolymer-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases.
5/2015	Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a rat model.
8/2010	In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases.
1/2009	Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khaled Greish Research Topics

Disease

46	Neoplasms (Cancer) 06/2021 - 03/2004
12	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2005
11	Triple Negative Breast Neoplasms 06/2021 - 08/2013
7	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 05/2011
4	Neoplasm Metastasis (Metastasis) 07/2015 - 08/2007
4	Head and Neck Neoplasms (Head and Neck Cancer) 08/2010 - 08/2009
3	Body Weight (Weight, Body) 09/2019 - 05/2012
3	Colonic Neoplasms (Colon Cancer) 01/2016 - 06/2004
3	Cardiotoxicity 07/2015 - 01/2009
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022 - 02/2008
2	COVID-19 04/2022 - 01/2022
2	Erectile Dysfunction 06/2021 - 01/2018
2	Infections 01/2019 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 11/2015
2	Necrosis 01/2016 - 08/2010
2	Colorectal Neoplasms (Colorectal Cancer) 07/2015 - 08/2007
1	Chronic Pain 06/2022
1	Pain (Aches) 06/2022
1	Lung Neoplasms (Lung Cancer) 02/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Amyloid Plaque 01/2022
1	Diabetes Mellitus 10/2020
1	Ulcerative Colitis 09/2019
1	Hyperglycemia 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Pathologic Processes 01/2019
1	Inflammation (Inflammations) 01/2018
1	Colitis 12/2017
1	Weight Gain 12/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2017
1	Diarrhea 12/2017

Drug/Important Bio-Agent (IBA)

20	Pharmaceutical PreparationsIBA 01/2022 - 06/2004
19	MicellesIBA 01/2019 - 06/2004
11	Styrene (Styrol)IBA 01/2019 - 01/2005
11	maleic acid (maleate)IBA 01/2019 - 01/2005
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
7	EnzymesIBA 01/2022 - 03/2004
7	PolymersIBA 05/2012 - 08/2007
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 06/2004
5	pirarubicinIBA 07/2015 - 01/2005
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021 - 03/2004
4	Raloxifene Hydrochloride (Evista)FDA Link 01/2019 - 01/2014
4	ProdrugsIBA 01/2016 - 07/2010
4	Heme Oxygenase-1IBA 01/2015 - 03/2004
4	silk elastin-like protein (SELP)IBA 08/2010 - 08/2009
3	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 05/2022 - 03/2004
3	Dasatinib (BMS 354825)FDA Link 06/2021 - 11/2015
3	Estrogen ReceptorsIBA 06/2021 - 11/2018
3	CannabinoidsIBA 12/2018 - 05/2015
3	Therapeutic UsesIBA 01/2018 - 08/2007
3	Dendrimers (Dendrons)IBA 10/2016 - 11/2012
3	copoly(styrene-maleic acid)-zinc protoporphyrinIBA 08/2012 - 04/2007
3	Silk FDA Link 07/2010 - 08/2009
2	SolutionsIBA 06/2022 - 03/2008
2	Tyrosine Kinase InhibitorsIBA 05/2022 - 11/2015
2	Sildenafil Citrate (Viagra)FDA Link 06/2021 - 01/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2021 - 11/2018
2	Insulin (Novolin)FDA Link 10/2020 - 01/2019
2	Hormones (Hormone)IBA 03/2020 - 09/2015
2	Dextran SulfateIBA 09/2019 - 12/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2017
2	CrizotinibIBA 01/2018 - 11/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 11/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 03/2004
2	Oxygen (Dioxygen)IBA 01/2016 - 08/2007
2	Tyrosine (L-Tyrosine)FDA Link 01/2016 - 11/2015
2	Hydroxyl RadicalIBA 06/2013 - 11/2012
2	AminesIBA 06/2013 - 11/2012
2	Evans Blue (Blue, Evans)FDA Link 08/2011 - 01/2009
2	hydroxypropyl methacrylateIBA 08/2011 - 05/2011
2	Thymidine KinaseIBA 08/2010 - 07/2010
2	LuciferasesIBA 07/2010 - 08/2009
2	HydrogelsIBA 12/2009 - 08/2009
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2008 - 02/2008
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2008 - 08/2007
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 03/2008 - 03/2004
2	pegylated zinc protoporphyrinIBA 08/2007 - 03/2004
2	Biliverdine (Biliverdin)IBA 08/2007 - 03/2004
1	Local AnestheticsIBA 06/2022
1	Neutralizing AntibodiesIBA 04/2022
1	BIBP COVID-19 vaccineIBA 04/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 06/2021
1	tafuramycin AIBA 06/2021
1	Aquaporins (Water Channels)IBA 06/2021
1	Interleukin-6 (Interleukin 6)IBA 09/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Biocompatible Materials (Biomaterials)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 11/2018
1	tert-dodecane S-nitrosothiolIBA 01/2018
1	CytokinesIBA 01/2018

Therapy/Procedure

17	Therapeutics 02/2022 - 03/2008
5	Drug Therapy (Chemotherapy) 01/2018 - 08/2007
2	Radiotherapy 01/2018 - 01/2016
2	Oral Administration 01/2016 - 01/2015
1	Cryosurgery 06/2021
1	Cryotherapy (Therapy, Cold) 06/2021